n-vinyl-2-pyrrolidinone has been researched along with tamoxifen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Devarajan, PV; Gaikwad, RV; Kapse, SV; Samad, A | 1 |
| Du, Q; Li, JJ; Yang, XL; Yang, YY; Yu, DG | 1 |
2 other study(ies) available for n-vinyl-2-pyrrolidinone and tamoxifen
| Article | Year |
|---|---|
Self nanoprecipitating preconcentrate of tamoxifen citrate for enhanced bioavailability.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Hormonal; Biological Availability; Chemical Precipitation; Dioctyl Sulfosuccinic Acid; Drug Design; Female; Hydrogen-Ion Concentration; Nanoparticles; Particle Size; Polysorbates; Povidone; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Surface Tension; Surface-Active Agents; Tamoxifen; Temperature | 2012 |
Fast dissolving drug delivery membrane based on the ultra-thin shell of electrospun core-shell nanofibers.
Topics: Drug Delivery Systems; Drug Liberation; Membranes, Artificial; Nanocomposites; Nanofibers; Polyesters; Povidone; Quercetin; Tamoxifen | 2018 |